Sweden’s EQT Raises Offer for Karo Pharma to SEK6.15 Billion

Swedish private-equity group EQT said Wednesday that it has increased its bid for Karo Pharma AB to 6.15 billion Swedish kronor ($692.4 million) from SEK5.94 billion.